SCHEMBL1768217

SCHEMBL1768217

Cn1ccc(=O)c(O)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL13386456 0.98 CA12 (0.57)
Glycerin SCHEMBL6955459 0.85 CA12 (0.46)
Xylitol SCHEMBL6955597 0.82 CA12 (0.44)
SCHEMBL8320257 0.74 CA12 (1.00)
SCHEMBL17233960 0.73
SCHEMBL9332437 0.73
SCHEMBL2606749 0.73
SCHEMBL10924548 0.73 TYR (0.50)
SCHEMBL4442471 0.71
SCHEMBL15495276 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0313305-A2 Photoprotection compositions comprising chelating agents THE PROCTER & GAMBLE COMPANY (US) 1989-04-26 EP claimed
EP-0145228-A1 Pharmaceutical compositions NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1985-06-19 EP claimed
US-20210395281-A1 MACROCYCLIC CHELATES AND USES THEREOF OXFORD FINANCE LLC 2021-12-23 US disclosed
EP-3285583-B1 SMALL MOLECULE INHIBITORS OF MCL-1 AND USES THEREOF UNIV MICHIGAN REGENTS (US) 2021-03-17 EP disclosed
US-10472362-B2 Fused tricyclic imidazo pyrazines as modulators of TNF activity UCB BIOPHARMA SPRL (BE) 2019-11-12 US disclosed
EP-3125884-B1 SMALL MOLECULE INHIBITORS OF MCL-1 AND USES THEREOF UNIV MICHIGAN REGENTS (US) 2019-11-06 EP disclosed
CN-109568652-A Promote the dressing composition of wound healing 粤肽生物科技(珠海)有限公司 2019-04-05 CN disclosed
US-20180222868-A1 Indazole Derivatives as Modulators of TNF Activity UCB PHARMA S.A. (BE) 2018-08-09 US disclosed
US-20180222868-A1 Indazole Derivatives as Modulators of TNF Activity UCB PHARMA S.A. (BE) 2018-08-09 US disclosed
US-10004737-B2 Fused imidazole and pyrazole derivatives as modulators of TNF activity UCB BIOPHARMA SPRL (BY) 2018-06-26 US disclosed
US-9988383-B2 Purine derivatives as modulators of TNF activity UCB BIOPHARMA SPRL (BE) 2018-06-05 US disclosed
CN-1072684-A Cephalosporins derivatives HOFFMANN LA ROCHE (CH) 1993-06-02 CN disclosed
CN-1038814-A Cephem compound and preparation method thereof FUJISAWA PHARMACEUTICAL CO (JP) 1990-01-17 CN disclosed
US-4894455-A Pharmaceutically active zinc complexes NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1990-01-16 US disclosed
US-4840958-A Novel 3-hydroxypyrid-2-ones and 3-hydroxyprid-4-ones useful in treating patients having a toxic concentration of iron NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1989-06-20 US disclosed
US-4665064-A IN BLOOD; ZINC CHELATE NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1987-05-12 US disclosed
EP-0093498-B1 PHARMACEUTICAL COMPOSITIONS CONTAINING N-SUBSTITUTED-3-HYDROXYPYRID-2-ONE OR -4-ONE DERIVATIVES NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1986-11-26 EP disclosed
US-4550101-A Iron complexes of hydroxy pyridones useful for treating iron deficiency anemia NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1985-10-29 US disclosed
EP-0145228-A1 Pharmaceutical compositions NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1985-06-19 EP disclosed
EP-0073143-A2 Novel complex amido and imido derivatives of carboxyalkyl peptides and thioethers and ethers of peptides Ryan, James Walter (US) 1983-03-02 EP disclosed